Propantheline bromide, >=97% (TLC), powder

Code: p8891-5g D2-231

Not available outside of the UK & Ireland.

Biochem/physiol Actions

Inhibits action of acetylcholine at post-ganglionic synapses; muscarinic acetylcholine receptor antagonist; antispasmodic; reduces gastric acid secret...


read more

Your Price
£114.00 5G

Not available outside of the UK & Ireland.

Biochem/physiol Actions

Inhibits action of acetylcholine at post-ganglionic synapses; muscarinic acetylcholine receptor antagonist; antispasmodic; reduces gastric acid secretion.

Features and Benefits

This compound was developed by Shire. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

5, 25 g in poly bottle

assay≥97% (TLC)
colorwhite to off-white
formpowder
Gene Informationhuman ... CHRM1(1128), CHRM2(1129), CHRM3(1131), CHRM4(1132), CHRM5(1133)
InChI keyXLBIBBZXLMYSFF-UHFFFAOYSA-M
InChI1S/C23H30NO3.BrH/c1-16(2)24(5,17(3)4)14-15-26-23(25)22-18-10-6-8-12-20(18)27-21-13-9-7-11-19(21)22;/h6-13,16-17,22H,14-15H2,1-5H3;1H/q+1;/p-1
originatorShire
Quality Level200
SMILES string[Br-].CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc3ccccc13)C(C)C
solubilityH2O: 50 mg/mL
Code
Description
Unit Size
List Price
Qty
P8891-25G
Unit:25G
List Price: £191.00
Source:List Price
ADD
Cas Number50-34-0
This product has met the following criteria to qualify for the following awards: